103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
SB3640

 

Introduced 2/9/2024, by Sen. Patrick J. Joyce

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/208  from Ch. 56 1/2, par. 1208
720 ILCS 570/309.1 new
720 ILCS 570/401  from Ch. 56 1/2, par. 1401

    Amends the Illinois Controlled Substances Act. Schedules Xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of Xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver Xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including Xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards.


LRB103 37597 RLC 69548 b

 

 

A BILL FOR

 

SB3640LRB103 37597 RLC 69548 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by changing Sections 208 and 401 and by adding Section
6309.1 as follows:
 
7    (720 ILCS 570/208)  (from Ch. 56 1/2, par. 1208)
8    Sec. 208. (a) The controlled substances listed in this
9Section are included in Schedule III.
10    (b) Unless specifically excepted or unless listed in
11another schedule, any material, compound, mixture, or
12preparation which contains any quantity of the following
13substances having a stimulant effect on the central nervous
14system, including its salts, isomers (whether optical
15position, or geometric), and salts of such isomers whenever
16the existence of such salts, isomers, and salts of isomers is
17possible within the specific chemical designation;
18        (1) Those compounds, mixtures, or preparations in
19    dosage unit form containing any stimulant substances
20    listed in Schedule II which compounds, mixtures, or
21    preparations were listed on August 25, 1971, as excepted
22    compounds under Title 21, Code of Federal Regulations,
23    Section 308.32, and any other drug of the quantitative

 

 

SB3640- 2 -LRB103 37597 RLC 69548 b

1    composition shown in that list for those drugs or which is
2    the same except that it contains a lesser quantity of
3    controlled substances;
4        (2) Benzphetamine;
5        (3) Chlorphentermine;
6        (4) Clortermine;
7        (5) Phendimetrazine.
8    (c) Unless specifically excepted or unless listed in
9another schedule, any material, compound, mixture, or
10preparation which contains any quantity of the following
11substances having a potential for abuse associated with a
12depressant effect on the central nervous system:
13        (1) Any compound, mixture, or preparation containing
14    amobarbital, secobarbital, pentobarbital or any salt
15    thereof and one or more other active medicinal ingredients
16    which are not listed in any schedule;
17        (2) Any suppository dosage form containing
18    amobarbital, secobarbital, pentobarbital or any salt of
19    any of these drugs and approved by the Federal Food and
20    Drug Administration for marketing only as a suppository;
21        (3) Any substance which contains any quantity of a
22    derivative of barbituric acid, or any salt thereof:
23        (3.1) Aprobarbital;
24        (3.2) Butabarbital (secbutabarbital);
25        (3.3) Butalbital;
26        (3.4) Butobarbital (butethal);

 

 

SB3640- 3 -LRB103 37597 RLC 69548 b

1        (4) Chlorhexadol;
2        (5) Methyprylon;
3        (6) Sulfondiethylmethane;
4        (7) Sulfonethylmethane;
5        (8) Sulfonmethane;
6        (9) Lysergic acid;
7        (10) Lysergic acid amide;
8        (10.1) Tiletamine or zolazepam or both, or any salt of
9    either of them.
10    Some trade or other names for a tiletamine-zolazepam
11    combination product: Telazol.
12    Some trade or other names for Tiletamine:
13    2-(ethylamino)-2-(2-thienyl)-cyclohexanone.
14    Some trade or other names for zolazepam:
15    4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-
16    [3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.
17        (11) Any material, compound, mixture or preparation
18    containing not more than 12.5 milligrams of pentazocine or
19    any of its salts, per 325 milligrams of aspirin;
20        (12) Any material, compound, mixture or preparation
21    containing not more than 12.5 milligrams of pentazocine or
22    any of its salts, per 325 milligrams of acetaminophen;
23        (13) Any material, compound, mixture or preparation
24    containing not more than 50 milligrams of pentazocine or
25    any of its salts plus naloxone HCl USP 0.5 milligrams, per
26    dosage unit;

 

 

SB3640- 4 -LRB103 37597 RLC 69548 b

1        (14) Ketamine;
2        (15) Thiopental; .
3        (16) Xylazine.
4    (d) Nalorphine.
5    (d.5) Buprenorphine.
6    (e) Unless specifically excepted or unless listed in
7another schedule, any material, compound, mixture, or
8preparation containing limited quantities of any of the
9following narcotic drugs, or their salts calculated as the
10free anhydrous base or alkaloid, as set forth below:
11        (1) not more than 1.8 grams of codeine per 100
12    milliliters or not more than 90 milligrams per dosage
13    unit, with an equal or greater quantity of an isoquinoline
14    alkaloid of opium;
15        (2) not more than 1.8 grams of codeine per 100
16    milliliters or not more than 90 milligrams per dosage
17    unit, with one or more active non-narcotic ingredients in
18    recognized therapeutic amounts;
19        (3) (blank);
20        (4) (blank);
21        (5) not more than 1.8 grams of dihydrocodeine per 100
22    milliliters or not more than 90 milligrams per dosage
23    unit, with one or more active, non-narcotic ingredients in
24    recognized therapeutic amounts;
25        (6) not more than 300 milligrams of ethylmorphine per
26    100 milliliters or not more than 15 milligrams per dosage

 

 

SB3640- 5 -LRB103 37597 RLC 69548 b

1    unit, with one or more active, non-narcotic ingredients in
2    recognized therapeutic amounts;
3        (7) not more than 500 milligrams of opium per 100
4    milliliters or per 100 grams, or not more than 25
5    milligrams per dosage unit, with one or more active,
6    non-narcotic ingredients in recognized therapeutic
7    amounts;
8        (8) not more than 50 milligrams of morphine per 100
9    milliliters or per 100 grams with one or more active,
10    non-narcotic ingredients in recognized therapeutic
11    amounts.
12    (f) Anabolic steroids, except the following anabolic
13steroids that are exempt:
14        (1) Androgyn L.A.;
15        (2) Andro-Estro 90-4;
16        (3) depANDROGYN;
17        (4) DEPO-T.E.;
18        (5) depTESTROGEN;
19        (6) Duomone;
20        (7) DURATESTRIN;
21        (8) DUO-SPAN II;
22        (9) Estratest;
23        (10) Estratest H.S.;
24        (11) PAN ESTRA TEST;
25        (12) Premarin with Methyltestosterone;
26        (13) TEST-ESTRO Cypionates;

 

 

SB3640- 6 -LRB103 37597 RLC 69548 b

1        (14) Testosterone Cyp 50 Estradiol Cyp 2;
2        (15) Testosterone Cypionate-Estradiol Cypionate
3    injection; and
4        (16) Testosterone Enanthate-Estradiol Valerate
5    injection.
6    (g) Hallucinogenic substances.
7        (1) Dronabinol (synthetic) in sesame oil and
8    encapsulated in a soft gelatin capsule in a U.S. Food and
9    Drug Administration approved product. Some other names for
10    dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-
11    6,6,9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1-ol) or
12    (-)-delta-9-(trans)-tetrahydrocannabinol.
13        (2) (Reserved).
14    (h) The Department may except by rule any compound,
15mixture, or preparation containing any stimulant or depressant
16substance listed in subsection (b) from the application of all
17or any part of this Act if the compound, mixture, or
18preparation contains one or more active medicinal ingredients
19not having a stimulant or depressant effect on the central
20nervous system, and if the admixtures are included therein in
21combinations, quantity, proportion, or concentration that
22vitiate the potential for abuse of the substances which have a
23stimulant or depressant effect on the central nervous system.
24(Source: P.A. 100-368, eff. 1-1-18.)
 
25    (720 ILCS 570/309.1 new)

 

 

SB3640- 7 -LRB103 37597 RLC 69548 b

1    Sec. 309.1. Veterinarian; Xylazine. Notwithstanding the
2scheduling of Xylazine as a Schedule III controlled substance,
3the prohibition on delivery or possession with intent to
4deliver Xylazine does not apply to licensed veterinarians who
5lawfully prescribe, dispense, administer, acquire, or use any
6controlled substance, including Xylazine, while acting in the
7course of their professional practice, in good faith, and in
8accordance with generally accepted medical standards.
 
9    (720 ILCS 570/401)  (from Ch. 56 1/2, par. 1401)
10    Sec. 401. Manufacture or delivery, or possession with
11intent to manufacture or deliver, a controlled substance, a
12counterfeit substance, or controlled substance analog. Except
13as authorized by this Act, it is unlawful for any person
14knowingly to manufacture or deliver, or possess with intent to
15manufacture or deliver, a controlled substance other than
16methamphetamine and other than bath salts as defined in the
17Bath Salts Prohibition Act sold or offered for sale in a retail
18mercantile establishment as defined in Section 16-0.1 of the
19Criminal Code of 2012, a counterfeit substance, or a
20controlled substance analog. A violation of this Act with
21respect to each of the controlled substances listed herein
22constitutes a single and separate violation of this Act. For
23purposes of this Section, "controlled substance analog" or
24"analog" means a substance, other than a controlled substance,
25which is not approved by the United States Food and Drug

 

 

SB3640- 8 -LRB103 37597 RLC 69548 b

1Administration or, if approved, is not dispensed or possessed
2in accordance with State or federal law, and that has a
3chemical structure substantially similar to that of a
4controlled substance in Schedule I or II, or that was
5specifically designed to produce an effect substantially
6similar to that of a controlled substance in Schedule I or II.
7Examples of chemical classes in which controlled substance
8analogs are found include, but are not limited to, the
9following: phenethylamines, N-substituted piperidines,
10morphinans, ecgonines, quinazolinones, substituted indoles,
11and arylcycloalkylamines. For purposes of this Act, a
12controlled substance analog shall be treated in the same
13manner as the controlled substance to which it is
14substantially similar.
15    (a) Any person who violates this Section with respect to
16the following amounts of controlled or counterfeit substances
17or controlled substance analogs, notwithstanding any of the
18provisions of subsections (c), (d), (e), (f), (g) or (h) to the
19contrary, is guilty of a Class X felony and shall be sentenced
20to a term of imprisonment as provided in this subsection (a)
21and fined as provided in subsection (b):
22        (1)(A) not less than 6 years and not more than 30 years
23    with respect to 15 grams or more but less than 100 grams of
24    a substance containing heroin, or an analog thereof;
25        (B) not less than 9 years and not more than 40 years
26    with respect to 100 grams or more but less than 400 grams

 

 

SB3640- 9 -LRB103 37597 RLC 69548 b

1    of a substance containing heroin, or an analog thereof;
2        (C) not less than 12 years and not more than 50 years
3    with respect to 400 grams or more but less than 900 grams
4    of a substance containing heroin, or an analog thereof;
5        (D) not less than 15 years and not more than 60 years
6    with respect to 900 grams or more of any substance
7    containing heroin, or an analog thereof;
8        (1.5)(A) not less than 6 years and not more than 30
9    years with respect to 15 grams or more but less than 100
10    grams of a substance containing fentanyl or xylazine, or
11    an analog thereof;
12        (B) not less than 9 years and not more than 40 years
13    with respect to 100 grams or more but less than 400 grams
14    of a substance containing fentanyl or xylazine, or an
15    analog thereof;
16        (C) not less than 12 years and not more than 50 years
17    with respect to 400 grams or more but less than 900 grams
18    of a substance containing fentanyl or xylazine, or an
19    analog thereof;
20        (D) not less than 15 years and not more than 60 years
21    with respect to 900 grams or more of a substance
22    containing fentanyl or xylazine, or an analog thereof;
23        (2)(A) not less than 6 years and not more than 30 years
24    with respect to 15 grams or more but less than 100 grams of
25    a substance containing cocaine, or an analog thereof;
26        (B) not less than 9 years and not more than 40 years

 

 

SB3640- 10 -LRB103 37597 RLC 69548 b

1    with respect to 100 grams or more but less than 400 grams
2    of a substance containing cocaine, or an analog thereof;
3        (C) not less than 12 years and not more than 50 years
4    with respect to 400 grams or more but less than 900 grams
5    of a substance containing cocaine, or an analog thereof;
6        (D) not less than 15 years and not more than 60 years
7    with respect to 900 grams or more of any substance
8    containing cocaine, or an analog thereof;
9        (3)(A) not less than 6 years and not more than 30 years
10    with respect to 15 grams or more but less than 100 grams of
11    a substance containing morphine, or an analog thereof;
12        (B) not less than 9 years and not more than 40 years
13    with respect to 100 grams or more but less than 400 grams
14    of a substance containing morphine, or an analog thereof;
15        (C) not less than 12 years and not more than 50 years
16    with respect to 400 grams or more but less than 900 grams
17    of a substance containing morphine, or an analog thereof;
18        (D) not less than 15 years and not more than 60 years
19    with respect to 900 grams or more of a substance
20    containing morphine, or an analog thereof;
21        (4) 200 grams or more of any substance containing
22    peyote, or an analog thereof;
23        (5) 200 grams or more of any substance containing a
24    derivative of barbituric acid or any of the salts of a
25    derivative of barbituric acid, or an analog thereof;
26        (6) 200 grams or more of any substance containing

 

 

SB3640- 11 -LRB103 37597 RLC 69548 b

1    amphetamine or any salt of an optical isomer of
2    amphetamine, or an analog thereof;
3        (6.5) (blank);
4        (6.6) (blank);
5        (7)(A) not less than 6 years and not more than 30 years
6    with respect to: (i) 15 grams or more but less than 100
7    grams of a substance containing lysergic acid diethylamide
8    (LSD), or an analog thereof, or (ii) 15 or more objects or
9    15 or more segregated parts of an object or objects but
10    less than 200 objects or 200 segregated parts of an object
11    or objects containing in them or having upon them any
12    amounts of any substance containing lysergic acid
13    diethylamide (LSD), or an analog thereof;
14        (B) not less than 9 years and not more than 40 years
15    with respect to: (i) 100 grams or more but less than 400
16    grams of a substance containing lysergic acid diethylamide
17    (LSD), or an analog thereof, or (ii) 200 or more objects or
18    200 or more segregated parts of an object or objects but
19    less than 600 objects or less than 600 segregated parts of
20    an object or objects containing in them or having upon
21    them any amount of any substance containing lysergic acid
22    diethylamide (LSD), or an analog thereof;
23        (C) not less than 12 years and not more than 50 years
24    with respect to: (i) 400 grams or more but less than 900
25    grams of a substance containing lysergic acid diethylamide
26    (LSD), or an analog thereof, or (ii) 600 or more objects or

 

 

SB3640- 12 -LRB103 37597 RLC 69548 b

1    600 or more segregated parts of an object or objects but
2    less than 1500 objects or 1500 segregated parts of an
3    object or objects containing in them or having upon them
4    any amount of any substance containing lysergic acid
5    diethylamide (LSD), or an analog thereof;
6        (D) not less than 15 years and not more than 60 years
7    with respect to: (i) 900 grams or more of any substance
8    containing lysergic acid diethylamide (LSD), or an analog
9    thereof, or (ii) 1500 or more objects or 1500 or more
10    segregated parts of an object or objects containing in
11    them or having upon them any amount of a substance
12    containing lysergic acid diethylamide (LSD), or an analog
13    thereof;
14    (7.5)(A) not less than 6 years and not more than 30 years
15    with respect to: (i) 15 grams or more but less than 100
16    grams of a substance listed in paragraph (1), (2), (2.1),
17    (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or
18    (26) of subsection (d) of Section 204, or an analog or
19    derivative thereof, or (ii) 15 or more pills, tablets,
20    caplets, capsules, or objects but less than 200 pills,
21    tablets, caplets, capsules, or objects containing in them
22    or having upon them any amounts of any substance listed in
23    paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20),
24    (20.1), (21), (25), or (26) of subsection (d) of Section
25    204, or an analog or derivative thereof;
26        (B) not less than 9 years and not more than 40 years

 

 

SB3640- 13 -LRB103 37597 RLC 69548 b

1    with respect to: (i) 100 grams or more but less than 400
2    grams of a substance listed in paragraph (1), (2), (2.1),
3    (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or
4    (26) of subsection (d) of Section 204, or an analog or
5    derivative thereof, or (ii) 200 or more pills, tablets,
6    caplets, capsules, or objects but less than 600 pills,
7    tablets, caplets, capsules, or objects containing in them
8    or having upon them any amount of any substance listed in
9    paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20),
10    (20.1), (21), (25), or (26) of subsection (d) of Section
11    204, or an analog or derivative thereof;
12        (C) not less than 12 years and not more than 50 years
13    with respect to: (i) 400 grams or more but less than 900
14    grams of a substance listed in paragraph (1), (2), (2.1),
15    (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or
16    (26) of subsection (d) of Section 204, or an analog or
17    derivative thereof, or (ii) 600 or more pills, tablets,
18    caplets, capsules, or objects but less than 1,500 pills,
19    tablets, caplets, capsules, or objects containing in them
20    or having upon them any amount of any substance listed in
21    paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20),
22    (20.1), (21), (25), or (26) of subsection (d) of Section
23    204, or an analog or derivative thereof;
24        (D) not less than 15 years and not more than 60 years
25    with respect to: (i) 900 grams or more of any substance
26    listed in paragraph (1), (2), (2.1), (2.2), (3), (14.1),

 

 

SB3640- 14 -LRB103 37597 RLC 69548 b

1    (19), (20), (20.1), (21), (25), or (26) of subsection (d)
2    of Section 204, or an analog or derivative thereof, or
3    (ii) 1,500 or more pills, tablets, caplets, capsules, or
4    objects containing in them or having upon them any amount
5    of a substance listed in paragraph (1), (2), (2.1), (2.2),
6    (3), (14.1), (19), (20), (20.1), (21), (25), or (26) of
7    subsection (d) of Section 204, or an analog or derivative
8    thereof;
9        (8) 30 grams or more of any substance containing
10    pentazocine or any of the salts, isomers and salts of
11    isomers of pentazocine, or an analog thereof;
12        (9) 30 grams or more of any substance containing
13    methaqualone or any of the salts, isomers and salts of
14    isomers of methaqualone, or an analog thereof;
15        (10) 30 grams or more of any substance containing
16    phencyclidine or any of the salts, isomers and salts of
17    isomers of phencyclidine (PCP), or an analog thereof;
18        (10.5) 30 grams or more of any substance containing
19    ketamine or any of the salts, isomers and salts of isomers
20    of ketamine, or an analog thereof;
21        (10.6) 100 grams or more of any substance containing
22    hydrocodone, or any of the salts, isomers and salts of
23    isomers of hydrocodone, or an analog thereof;
24        (10.7) (blank);
25        (10.8) 100 grams or more of any substance containing
26    dihydrocodeine, or any of the salts, isomers and salts of

 

 

SB3640- 15 -LRB103 37597 RLC 69548 b

1    isomers of dihydrocodeine, or an analog thereof;
2        (10.9) 100 grams or more of any substance containing
3    oxycodone, or any of the salts, isomers and salts of
4    isomers of oxycodone, or an analog thereof;
5        (11) 200 grams or more of any substance containing any
6    other controlled substance classified in Schedules I or
7    II, or an analog thereof, which is not otherwise included
8    in this subsection.
9    (b) Any person sentenced with respect to violations of
10paragraph (1), (2), (3), (7), or (7.5) of subsection (a)
11involving 100 grams or more of the controlled substance named
12therein, may in addition to the penalties provided therein, be
13fined an amount not more than $500,000 or the full street value
14of the controlled or counterfeit substance or controlled
15substance analog, whichever is greater. The term "street
16value" shall have the meaning ascribed in Section 110-5 of the
17Code of Criminal Procedure of 1963. Any person sentenced with
18respect to any other provision of subsection (a), may in
19addition to the penalties provided therein, be fined an amount
20not to exceed $500,000.
21    (b-1) Excluding violations of this Act when the controlled
22substance is fentanyl, any person sentenced to a term of
23imprisonment with respect to violations of Section 401, 401.1,
24405, 405.1, 405.2, or 407, when the substance containing the
25controlled substance contains any amount of fentanyl, 3 years
26shall be added to the term of imprisonment imposed by the

 

 

SB3640- 16 -LRB103 37597 RLC 69548 b

1court, and the maximum sentence for the offense shall be
2increased by 3 years.
3    (c) Any person who violates this Section with regard to
4the following amounts of controlled or counterfeit substances
5or controlled substance analogs, notwithstanding any of the
6provisions of subsections (a), (b), (d), (e), (f), (g) or (h)
7to the contrary, is guilty of a Class 1 felony. The fine for
8violation of this subsection (c) shall not be more than
9$250,000:
10        (1) 1 gram or more but less than 15 grams of any
11    substance containing heroin, or an analog thereof;
12        (1.5) 1 gram or more but less than 15 grams of any
13    substance containing fentanyl, or an analog thereof;
14        (2) 1 gram or more but less than 15 grams of any
15    substance containing cocaine, or an analog thereof;
16        (2.5) 1 gram or more but less than 15 grams of any
17    substance containing xylazine, or an analog thereof;
18        (3) 10 grams or more but less than 15 grams of any
19    substance containing morphine, or an analog thereof;
20        (4) 50 grams or more but less than 200 grams of any
21    substance containing peyote, or an analog thereof;
22        (5) 50 grams or more but less than 200 grams of any
23    substance containing a derivative of barbituric acid or
24    any of the salts of a derivative of barbituric acid, or an
25    analog thereof;
26        (6) 50 grams or more but less than 200 grams of any

 

 

SB3640- 17 -LRB103 37597 RLC 69548 b

1    substance containing amphetamine or any salt of an optical
2    isomer of amphetamine, or an analog thereof;
3        (6.5) (blank);
4        (7)(i) 5 grams or more but less than 15 grams of any
5    substance containing lysergic acid diethylamide (LSD), or
6    an analog thereof, or (ii) more than 10 objects or more
7    than 10 segregated parts of an object or objects but less
8    than 15 objects or less than 15 segregated parts of an
9    object containing in them or having upon them any amount
10    of any substance containing lysergic acid diethylamide
11    (LSD), or an analog thereof;
12        (7.5)(i) 5 grams or more but less than 15 grams of any
13    substance listed in paragraph (1), (2), (2.1), (2.2), (3),
14    (14.1), (19), (20), (20.1), (21), (25), or (26) of
15    subsection (d) of Section 204, or an analog or derivative
16    thereof, or (ii) more than 10 pills, tablets, caplets,
17    capsules, or objects but less than 15 pills, tablets,
18    caplets, capsules, or objects containing in them or having
19    upon them any amount of any substance listed in paragraph
20    (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1),
21    (21), (25), or (26) of subsection (d) of Section 204, or an
22    analog or derivative thereof;
23        (8) 10 grams or more but less than 30 grams of any
24    substance containing pentazocine or any of the salts,
25    isomers and salts of isomers of pentazocine, or an analog
26    thereof;

 

 

SB3640- 18 -LRB103 37597 RLC 69548 b

1        (9) 10 grams or more but less than 30 grams of any
2    substance containing methaqualone or any of the salts,
3    isomers and salts of isomers of methaqualone, or an analog
4    thereof;
5        (10) 10 grams or more but less than 30 grams of any
6    substance containing phencyclidine or any of the salts,
7    isomers and salts of isomers of phencyclidine (PCP), or an
8    analog thereof;
9        (10.5) 10 grams or more but less than 30 grams of any
10    substance containing ketamine or any of the salts, isomers
11    and salts of isomers of ketamine, or an analog thereof;
12        (10.6) 50 grams or more but less than 100 grams of any
13    substance containing hydrocodone, or any of the salts,
14    isomers and salts of isomers of hydrocodone, or an analog
15    thereof;
16        (10.7) (blank);
17        (10.8) 50 grams or more but less than 100 grams of any
18    substance containing dihydrocodeine, or any of the salts,
19    isomers and salts of isomers of dihydrocodeine, or an
20    analog thereof;
21        (10.9) 50 grams or more but less than 100 grams of any
22    substance containing oxycodone, or any of the salts,
23    isomers and salts of isomers of oxycodone, or an analog
24    thereof;
25        (11) 50 grams or more but less than 200 grams of any
26    substance containing a substance classified in Schedules I

 

 

SB3640- 19 -LRB103 37597 RLC 69548 b

1    or II, or an analog thereof, which is not otherwise
2    included in this subsection.
3    (c-5) (Blank).
4    (d) Any person who violates this Section with regard to
5any other amount of a controlled or counterfeit substance
6containing dihydrocodeine or classified in Schedules I or II,
7or an analog thereof, which is (i) a narcotic drug, (ii)
8lysergic acid diethylamide (LSD) or an analog thereof, (iii)
9any substance containing amphetamine or fentanyl or xylazine
10or any salt or optical isomer of amphetamine or fentanyl or
11xylazine, or an analog thereof, or (iv) any substance
12containing N-Benzylpiperazine (BZP) or any salt or optical
13isomer of N-Benzylpiperazine (BZP), or an analog thereof, is
14guilty of a Class 2 felony. The fine for violation of this
15subsection (d) shall not be more than $200,000.
16    (d-5) (Blank).
17    (e) Any person who violates this Section with regard to
18any other amount of a controlled substance other than
19methamphetamine or counterfeit substance classified in
20Schedule I or II, or an analog thereof, which substance is not
21included under subsection (d) of this Section, is guilty of a
22Class 3 felony. The fine for violation of this subsection (e)
23shall not be more than $150,000.
24    (f) Any person who violates this Section with regard to
25any other amount of a controlled or counterfeit substance
26classified in Schedule III is guilty of a Class 3 felony. The

 

 

SB3640- 20 -LRB103 37597 RLC 69548 b

1fine for violation of this subsection (f) shall not be more
2than $125,000.
3    (g) Any person who violates this Section with regard to
4any other amount of a controlled or counterfeit substance
5classified in Schedule IV is guilty of a Class 3 felony. The
6fine for violation of this subsection (g) shall not be more
7than $100,000.
8    (h) Any person who violates this Section with regard to
9any other amount of a controlled or counterfeit substance
10classified in Schedule V is guilty of a Class 3 felony. The
11fine for violation of this subsection (h) shall not be more
12than $75,000.
13    (i) This Section does not apply to the manufacture,
14possession or distribution of a substance in conformance with
15the provisions of an approved new drug application or an
16exemption for investigational use within the meaning of
17Section 505 of the Federal Food, Drug and Cosmetic Act.
18    (j) (Blank).
19(Source: P.A. 99-371, eff. 1-1-16; 99-585, eff. 1-1-17;
20100-368, eff. 1-1-18.)